A Clinical Study of Darcilil Combined With AI Combined With Pyrrotinib in the Treatment of TPBC

NCT06235931 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

34

Enrollment

OTHER

Sponsor class

Conditions

Breast Neoplasms

Interventions

DRUG: Darcilide +AI (letrozole/anastrozole/Exemestane) + pyrrotinib

Sponsor

Second Affiliated Hospital of Soochow University